Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""neutralization"" wg kryterium: Temat


Tytuł :
Quantification of SARS-CoV-2 neutralizing antibody by wild-type plaque reduction neutralization, microneutralization and pseudotyped virus neutralization assays.
Autorzy :
Bewley KR; National Infection Service, Public Health England, Salisbury, UK. .
Coombes NS; National Infection Service, Public Health England, Salisbury, UK.
Gagnon L; Nexelis, Laval, Quebec, Canada.
McInroy L; National Infection Service, Public Health England, Salisbury, UK.
Baker N; National Infection Service, Public Health England, Salisbury, UK.
Shaik I; National Infection Service, Public Health England, Salisbury, UK.
St-Jean JR; Nexelis, Laval, Quebec, Canada.
St-Amant N; Nexelis, Laval, Quebec, Canada.
Buttigieg KR; National Infection Service, Public Health England, Salisbury, UK.
Humphries HE; National Infection Service, Public Health England, Salisbury, UK.
Godwin KJ; National Infection Service, Public Health England, Salisbury, UK.
Brunt E; National Infection Service, Public Health England, Salisbury, UK.
Allen L; National Infection Service, Public Health England, Salisbury, UK.
Leung S; National Infection Service, Public Health England, Salisbury, UK.
Brown PJ; National Infection Service, Public Health England, Salisbury, UK.
Penn EJ; National Infection Service, Public Health England, Salisbury, UK.
Thomas K; National Infection Service, Public Health England, Salisbury, UK.
Kulnis G; Nexelis, Laval, Quebec, Canada.
Hallis B; National Infection Service, Public Health England, Salisbury, UK.
Carroll M; National Infection Service, Public Health England, Salisbury, UK.
Funnell S; National Infection Service, Public Health England, Salisbury, UK.
Charlton S; National Infection Service, Public Health England, Salisbury, UK.
Pokaż więcej
Źródło :
Nature protocols [Nat Protoc] 2021 Jun; Vol. 16 (6), pp. 3114-3140. Date of Electronic Publication: 2021 Apr 23.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
COVID-19/*immunology
Neutralization Tests/*methods
SARS-CoV-2/*immunology
Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; COVID-19/blood ; COVID-19/prevention & control ; COVID-19 Vaccines/immunology ; COVID-19 Vaccines/therapeutic use ; Humans ; Neutralization Tests/economics ; Time Factors
Czasopismo naukowe
Tytuł :
Predicting the presence and titre of rabies virus-neutralizing antibodies from low-volume serum samples in low-containment facilities.
Autorzy :
Meza DK; Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Medical Research Council, University of Glasgow Centre for Virus Research, Glasgow, UK.
Broos A; Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Medical Research Council, University of Glasgow Centre for Virus Research, Glasgow, UK.
Becker DJ; Department of Biology, Indiana University, Bloomington, IN, USA.
Behdenna A; Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Willett BJ; Medical Research Council, University of Glasgow Centre for Virus Research, Glasgow, UK.
Viana M; Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Streicker DG; Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.; Medical Research Council, University of Glasgow Centre for Virus Research, Glasgow, UK.
Pokaż więcej
Źródło :
Transboundary and emerging diseases [Transbound Emerg Dis] 2021 May; Vol. 68 (3), pp. 1564-1576. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
Dog Diseases/*blood
Neutralization Tests/*veterinary
Rabies/*veterinary
Rabies virus/*isolation & purification
Animals ; Dogs ; Green Fluorescent Proteins/chemistry ; Neutralization Tests/instrumentation ; Rabies/blood
Czasopismo naukowe
Tytuł :
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.
Autorzy :
Wibmer CK; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Ayres F; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Hermanus T; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Madzivhandila M; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Kgagudi P; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Oosthuysen B; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
Lambson BE; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.; Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
de Oliveira T; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Department of Laboratory Medicine & Medical Sciences, University of KwaZulu-Natal, Durban, South Africa, Durban, South Africa.
Vermeulen M; South African National Blood Service, Weltevreden Park, South Africa.
van der Berg K; South African National Blood Service, Weltevreden Park, South Africa.; Division of Clinical Haematology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Rossouw T; Department of Immunology, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
Boswell M; Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa.
Ueckermann V; Division for Infectious Diseases, Department of Internal Medicine, Steve Biko Academic Hospital and University of Pretoria, Pretoria, South Africa.
Meiring S; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.
von Gottberg A; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.; Department of Clinical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Cohen C; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Morris L; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.; Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Bhiman JN; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa.; Department of Virology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Moore PL; National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa. .; Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Apr; Vol. 27 (4), pp. 622-625. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Immune Evasion*
Neutralization Tests*
COVID-19/*immunology
SARS-CoV-2/*immunology
Antibodies, Viral/chemistry ; Antibodies, Viral/immunology ; Blood Donors ; COVID-19 Vaccines/immunology ; Humans ; Spike Glycoprotein, Coronavirus/immunology
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.
Autorzy :
Xie X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Liu Y; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Liu J; Departments of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Zhang X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Zou J; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Fontes-Garfias CR; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Xia H; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Swanson KA; Pfizer, Pearl River, NY, USA.
Cutler M; Pfizer, Pearl River, NY, USA.
Cooper D; Pfizer, Pearl River, NY, USA.
Menachery VD; Departments of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Weaver SC; Departments of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA.
Dormitzer PR; Pfizer, Pearl River, NY, USA. .
Shi PY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. .; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA. .; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX, USA. .; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA. .; Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2021 Apr; Vol. 27 (4), pp. 620-621. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Mutation*
Neutralization Tests*
COVID-19 Vaccines/*immunology
SARS-CoV-2/*immunology
Spike Glycoprotein, Coronavirus/*genetics
Humans ; Spike Glycoprotein, Coronavirus/immunology ; Vaccination
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera.
Autorzy :
Perera RAPM; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Ko R; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Tsang OTY; Infectious Diseases Centre, Princess Margaret Hospital, Hospital Authority of Hong Kong, Kwai Chung, Hong Kong Special Administrative Region, China.
Hui DSC; Department of Medicine and Therapeutics, Prince of Wales Hospital, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China.
Kwan MYM; Department of Paediatric and Adolescent Medicine, Princess Margaret Hospital, Hospital Authority of Hong Kong, Kwai Chung, Hong Kong Special Administrative Region, China.
Brackman CJ; Agriculture, Fisheries and Conservation Department, Government of the Hong Kong Special Administrative Region, Hong Kong Special Administrative Region, China.
To EMW; Agriculture, Fisheries and Conservation Department, Government of the Hong Kong Special Administrative Region, Hong Kong Special Administrative Region, China.
Yen HL; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Leung K; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.; Laboratory of Data Discovery for Health (D4H), New Territories, Hong Kong Special Administrative Region, China.
Cheng SMS; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Chan KH; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Chan KCK; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Li KC; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Saif L; Food Animal Health Research Program, OARDC/The Ohio State University, Wooster, Ohio, USA.
Barrs VR; Jockey Club College of Veterinary Medicine & Life Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong Special Administrative Region, China.
Wu JT; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.; Laboratory of Data Discovery for Health (D4H), New Territories, Hong Kong Special Administrative Region, China.
Sit THC; Agriculture, Fisheries and Conservation Department, Government of the Hong Kong Special Administrative Region, Hong Kong Special Administrative Region, China.
Poon LLM; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.; HKU-Pasteur Research Pole, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Peiris M; School of Public Health, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China .; HKU-Pasteur Research Pole, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong Special Administrative Region, China.
Pokaż więcej
Źródło :
Journal of clinical microbiology [J Clin Microbiol] 2021 Jan 21; Vol. 59 (2). Date of Electronic Publication: 2021 Jan 21 (Print Publication: 2021).
Typ publikacji :
Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*diagnosis
COVID-19 Serological Testing/*methods
Neutralization Tests/*methods
SARS-CoV-2/*isolation & purification
Animals ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; COVID-19/blood ; COVID-19/pathology ; Cats ; Cricetinae ; Cross Reactions ; Dogs ; Female ; Humans ; Immune Sera/immunology ; Male ; Neutralization Tests/standards ; SARS-CoV-2/immunology ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Viral Infectivity Quantification and Neutralization Assays Using Laser Force Cytology.
Autorzy :
Hebert CG; LumaCyte, LLC, Charlottesville, VA, USA. .
Rodrigues KL; LumaCyte, LLC, Charlottesville, VA, USA.
DiNardo N; Thermo Fisher Scientific Inc., Grand Island, NY, USA.
Hachmann AB; Thermo Fisher Scientific Inc., Grand Island, NY, USA.
Pokaż więcej
Źródło :
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2183, pp. 575-585.
Typ publikacji :
Journal Article
MeSH Terms :
Neutralization Tests*
Viral Load*
Viral Plaque Assay*
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Virus Diseases/*immunology
Virus Diseases/*virology
Animals ; Cell Adhesion ; Chlorocebus aethiops ; HEK293 Cells ; Humans ; Sf9 Cells ; Vaccines/immunology ; Vero Cells ; Virus Diseases/prevention & control
Czasopismo naukowe
Tytuł :
SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays.
Autorzy :
Walker GJ; Virology Research Laboratory, Prince of Wales Hospital, Sydney, NSW 2031, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
Naing Z; Serology and Virology Division (SaViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Ospina Stella A; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Yeang M; Virology Research Laboratory, Prince of Wales Hospital, Sydney, NSW 2031, Australia.; Serology and Virology Division (SaViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Caguicla J; Serology and Virology Division (SaViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Ramachandran V; Serology and Virology Division (SaViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Isaacs SR; Virology Research Laboratory, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
Agapiou D; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Bull RA; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Stelzer-Braid S; Virology Research Laboratory, Prince of Wales Hospital, Sydney, NSW 2031, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.
Daly J; Australian Red Cross Lifeblood, 417 St Kilda Rd, Melbourne, VIC 3004, Australia.
Gosbell IB; Australian Red Cross Lifeblood, 417 St Kilda Rd, Melbourne, VIC 3004, Australia.; School of Medicine, Western Sydney University, Penrith, NSW 2747, Australia.
Hoad VC; Australian Red Cross Lifeblood, 417 St Kilda Rd, Melbourne, VIC 3004, Australia.
Irving DO; Australian Red Cross Lifeblood, 417 St Kilda Rd, Melbourne, VIC 3004, Australia.; Faculty of Health, University of Technology, Sydney, NSW 2007, Australia.
Pink JM; Australian Red Cross Lifeblood, 417 St Kilda Rd, Melbourne, VIC 3004, Australia.
Turville S; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Kelleher AD; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Rawlinson WD; Virology Research Laboratory, Prince of Wales Hospital, Sydney, NSW 2031, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, NSW 2052, Australia.; Serology and Virology Division (SaViD), NSW Health Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.; School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney, NSW 2052, Australia.
Pokaż więcej
Źródło :
Viruses [Viruses] 2021 Feb 04; Vol. 13 (2). Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19 Serological Testing*
Enzyme-Linked Immunosorbent Assay*
Neutralization Tests*
Antibodies, Viral/*blood
COVID-19/*immunology
SARS-CoV-2/*immunology
COVID-19/diagnosis ; Humans ; Immunoglobulin A/blood ; Immunoglobulin G/blood ; ROC Curve ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Peptide enzyme-linked immunosorbent assay (pELISA) as a possible alternative to the neutralization test for evaluating the immune response to IBV vaccine.
Autorzy :
Wu Q; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.
Lin Z; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.
Wu J; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.
Qian K; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; The International Joint Laboratory for Cooperation in Agriculture and Agricultural Product Safety, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.
Shao H; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.; The International Joint Laboratory for Cooperation in Agriculture and Agricultural Product Safety, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China.
Ye J; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; The International Joint Laboratory for Cooperation in Agriculture and Agricultural Product Safety, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Ministry of Education Key Lab for Avian Preventive Medicine, Yangzhou University, No. 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .
Qin A; Key Laboratory of Avian Preventive Medicine, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Jiangsu Key Lab of Zoonosis, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; The International Joint Laboratory for Cooperation in Agriculture and Agricultural Product Safety, Ministry of Education, Yangzhou University, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .; Ministry of Education Key Lab for Avian Preventive Medicine, Yangzhou University, No. 12 East Wenhui Road, 225009, Yangzhou, Jiangsu, P.R. China. .
Pokaż więcej
Źródło :
BMC veterinary research [BMC Vet Res] 2021 Jan 25; Vol. 17 (1), pp. 51. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji :
Journal Article
MeSH Terms :
Enzyme-Linked Immunosorbent Assay*/methods
Neutralization Tests*/methods
Coronavirus Infections/*prevention & control
Infectious bronchitis virus/*immunology
Poultry Diseases/*prevention & control
Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Chickens/immunology ; Chickens/virology ; Coronavirus Infections/immunology ; Poultry Diseases/immunology ; Poultry Diseases/virology ; Reproducibility of Results ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Seroprevalence of Toscana Virus and Sandfly Fever Sicilian Virus in European Bat Colonies Measured Using a Neutralization Test.
Autorzy :
Ayhan N; Unité des Virus Emergents, Aix Marseille University, IRD 190, INSERM U1207, 13005 Marseille, France.; UR7310, Laboratoire de Virologie, Université de Corse-Inserm, 20250 Corte, France.
López-Roig M; Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.; Biodiversity Research Institute, University of Barcelona, 08028 Barcelona, Spain.
Monastiri A; Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.
Charrel RN; Unité des Virus Emergents, Aix Marseille University, IRD 190, INSERM U1207, 13005 Marseille, France.
Serra-Cobo J; Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain.; Biodiversity Research Institute, University of Barcelona, 08028 Barcelona, Spain.
Pokaż więcej
Źródło :
Viruses [Viruses] 2021 Jan 11; Vol. 13 (1). Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neutralization Tests*/methods
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
Chiroptera/*immunology
Chiroptera/*virology
Phlebotomus Fever/*epidemiology
Phlebotomus Fever/*transmission
Sandfly fever Naples virus/*immunology
Animals ; Geography ; Phlebotomus Fever/immunology ; Sandfly fever Naples virus/isolation & purification ; Seroepidemiologic Studies ; Spain/epidemiology
Czasopismo naukowe
Tytuł :
Neutralizing Antibody Responses in COVID-19 Convalescent Sera.
Autorzy :
Lee WT; Wadsworth Center, New York State Department of Health, Albany, New York, USA.; Department of Biomedical Sciences, School of Public Health, State University of New York at Albany, Albany, New York, USA.
Girardin RC; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Dupuis AP; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Kulas KE; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Payne AF; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Wong SJ; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Arinsburg S; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Nguyen FT; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Mendu DR; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Firpo-Betancourt A; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Jhang J; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Wajnberg A; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Krammer F; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Cordon-Cardo C; Department of Pathology, Molecular, and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Amler S; Westchester County Department of Health, White Plains, New York, USA.
Montecalvo M; Westchester County Department of Health, White Plains, New York, USA.
Hutton B; New York State Department of Health, Albany, New York, USA.
Taylor J; Wadsworth Center, New York State Department of Health, Albany, New York, USA.
McDonough KA; Wadsworth Center, New York State Department of Health, Albany, New York, USA.; Department of Biomedical Sciences, School of Public Health, State University of New York at Albany, Albany, New York, USA.
Pokaż więcej
Źródło :
The Journal of infectious diseases [J Infect Dis] 2021 Jan 04; Vol. 223 (1), pp. 47-55.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neutralization Tests*
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
COVID-19/*therapy
Enzyme-Linked Immunosorbent Assay ; Humans ; Immunization, Passive
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
High-throughput viral microneutralization method for feline coronavirus using image cytometry.
Autorzy :
Pearson M; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, 80523, United States.
LaVoy A; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, 80523, United States.
Chan LL; Department of Advanced Technology R&D, Nexcelom Bioscience LLC, Lawrence, MA, 01843, United States. Electronic address: .
Dean GA; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, 80523, United States.
Pokaż więcej
Źródło :
Journal of virological methods [J Virol Methods] 2020 Dec; Vol. 286, pp. 113979. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Coronavirus Infections/*veterinary
Coronavirus, Feline/*isolation & purification
High-Throughput Screening Assays/*veterinary
Image Cytometry/*methods
Neutralization Tests/*methods
Animals ; Cat Diseases/diagnosis ; Cat Diseases/virology ; Cats ; Cell Line ; Coronavirus Infections/diagnosis ; Coronavirus Infections/virology ; Feline Infectious Peritonitis/diagnosis ; Feline Infectious Peritonitis/virology ; High-Throughput Screening Assays/methods ; Image Cytometry/veterinary ; Neutralization Tests/veterinary ; Viral Load
Czasopismo naukowe
Tytuł :
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.
Autorzy :
Nie J; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Li Q; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.; Graduate School of Peking Union Medical College, Beijing, People's Republic of China.
Wu J; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.; Wuhan Institute of Biological Products, Wuhan, People's Republic of China.
Zhao C; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Hao H; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Liu H; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Zhang L; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Nie L; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Qin H; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Wang M; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Lu Q; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Li X; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Sun Q; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Liu J; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Fan C; Division of Animal Model Research, Institute for Laboratory Animal Resources, National Institutes for Food and Drug Control, Beijing, People's Republic of China.
Huang W; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.
Xu M; Institute for Biological Product Control, National Institutes for Food and Drug Control, Beijing, People's Republic of China.
Wang Y; Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC), Beijing, People's Republic of China.; Graduate School of Peking Union Medical College, Beijing, People's Republic of China.
Pokaż więcej
Źródło :
Emerging microbes & infections [Emerg Microbes Infect] 2020 Dec; Vol. 9 (1), pp. 680-686.
Typ publikacji :
Journal Article; Validation Study
MeSH Terms :
Neutralization Tests*
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Betacoronavirus/*immunology
Coronavirus Infections/*immunology
Immune Sera/*immunology
Pneumonia, Viral/*immunology
Spike Glycoprotein, Coronavirus/*immunology
Animals ; COVID-19 ; Cell Line ; Coronavirus Infections/therapy ; Humans ; Immunization, Passive ; Limit of Detection ; Membrane Glycoproteins/immunology ; Mice ; Plasmids ; Reproducibility of Results ; SARS-CoV-2 ; Sensitivity and Specificity ; Spike Glycoprotein, Coronavirus/genetics ; Vesicular stomatitis Indiana virus/genetics ; Viral Envelope Proteins/immunology ; Virus Internalization
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
A comparison of SARS-CoV-2 antibody assays evaluated in Auckland, New Zealand.
Autorzy :
Fox-Lewis S; Clinical Virology Registrar, Department of Virology-Immunology, LabPLUS, Auckland City Hospital, Auckland.
Whitcombe A; PhD Student, Faculty of Medical and Health Sciences, University of Auckland, Auckland; Maurice Wilkins Centre, University of Auckland, Auckland.
McGregor R; Post-Doctoral Research Fellow, Faculty of Medical and Health Sciences, University of Auckland, Auckland; Maurice Wilkins Centre, University of Auckland, Auckland.
Carlton L; Research Technician, Faculty of Medical and Health Sciences, University of Auckland, Auckland.
Hwang Y; Registered Medical Laboratory Scientist, Department of Virology-Immunology, LabPLUS, Auckland City Hospital, Auckland.
Austin P; Section Leader For Serology, Department of Virology-Immunology, LabPLUS, Auckland City Hospital, Auckland.
Aspin L; Head of the Department of Biochemistry and Immunology, Department of Biochemistry and Immunology, Labtests, Auckland.
Raill B; Section Head for Toxicology and Immunoassay, Department of Biochemistry, Middlemore Hospital, Auckland.
Webb R; Consultant Paediatrician, Paediatric Infectious Diseases, Faculty of Medical and Health Sciences, University of Auckland, Auckland; Starship Children's Hospital, Auckland; KidzFirst Children's Hospital, Middlemore Hospital, Auckland.
Taylor S; Clinical Microbiologist, Department of Microbiology, Middlemore Hospital, Auckland.
Morpeth S; Clinical Microbiologist, Department of Microbiology, Middlemore Hospital, Auckland.
Roberts S; Clinical Microbiologist, Head of Department of Microbiology Maurice Wilkins Centre, University of Auckland, Auckland; Department of Microbiology, LabPLUS, Auckland City Hospital, Auckland.
Moreland NJ; Senior Lecturer, Faculty of Medical and Health Sciences, University of Auckland, Auckland; Maurice Wilkins Centre, University of Auckland, Auckland.
McAuliffe G; Clinical Microbiologist, Head of Department of Virology, Department of Virology-Immunology, LabPLUS, Auckland City Hospital, Auckland; Department of Microbiology, Labtests, Auckland.
Pokaż więcej
Źródło :
The New Zealand medical journal [N Z Med J] 2020 Nov 20; Vol. 133 (1525), pp. 127-131. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Letter
MeSH Terms :
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/immunology
COVID-19*/virology
COVID-19 Serological Testing*/methods
COVID-19 Serological Testing*/standards
Neutralization Tests*/methods
Neutralization Tests*/standards
SARS-CoV-2*/immunology
SARS-CoV-2*/isolation & purification
Clinical Laboratory Techniques/methods ; Clinical Laboratory Techniques/standards ; Comparative Effectiveness Research ; Humans ; New Zealand/epidemiology ; Predictive Value of Tests ; Reagent Kits, Diagnostic/classification ; Sensitivity and Specificity
Opinia redakcyjna
Tytuł :
Development of a receptor-based inhibitory penta-unit-conjugated peptide to enhance anthrax toxin neutralization.
Autorzy :
Lee SC; Department of Chemistry, Georgia State University, Atlanta, GA 30303, USA. Electronic address: .
Yoon MY; Department of Chemistry and Research Institute for Natural Sciences, Hanyang University, Seoul 04763, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
International journal of biological macromolecules [Int J Biol Macromol] 2020 Nov 15; Vol. 163, pp. 327-335. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Journal Article
MeSH Terms :
Neutralization Tests*
Antigens, Bacterial/*chemistry
Bacterial Toxins/*chemistry
Oligosaccharides/*chemistry
Oligosaccharides/*pharmacology
Peptides/*chemistry
Peptides/*pharmacology
Receptors, Peptide/*antagonists & inhibitors
Receptors, Peptide/*chemistry
Animals ; Cell Surface Display Techniques ; Humans ; Macrophages ; Mice ; Peptide Library ; Protein Binding ; RAW 264.7 Cells ; Structure-Activity Relationship
Czasopismo naukowe
Tytuł :
Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein.
Autorzy :
Dong J; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Cross RW; Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Doyle MP; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Kose N; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Mousa JJ; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Annand EJ; Sydney School of Veterinary Science and Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, Sydney, NSW, Australia; Black Mountain Laboratories & Australian Centre for Disease Preparedness, Health and Biosecurity, CSIRO, Canberra, ACT, Australia.
Borisevich V; Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Agans KN; Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Sutton R; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Nargi R; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Majedi M; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Fenton KA; Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Reichard W; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Bombardi RG; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Geisbert TW; Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA.
Crowe JE Jr; The Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; Department of Microbiology & Immunology, The University of Texas Medical Branch, Galveston, TX 77555, USA; Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Electronic address: .
Pokaż więcej
Źródło :
Cell [Cell] 2020 Dec 10; Vol. 183 (6), pp. 1536-1550.e17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Neutralization Tests*
Antibodies, Neutralizing/*immunology
Antibodies, Viral/*immunology
Hendra Virus/*immunology
Henipavirus/*immunology
Nipah Virus/*immunology
Receptors, Virus/*immunology
Amino Acid Sequence ; Animals ; Antibodies, Monoclonal/chemistry ; Antibodies, Monoclonal/isolation & purification ; Antigens, Viral/immunology ; Binding Sites ; Binding, Competitive ; Brain/pathology ; Chiroptera/virology ; Cross Reactions/immunology ; Crystallography, X-Ray ; Ephrin-B2/metabolism ; Female ; Ferrets/virology ; Humans ; Interferometry ; Liver/pathology ; Models, Molecular ; Protein Binding ; Protein Conformation ; Protein Domains ; Receptors, Virus/chemistry ; Receptors, Virus/metabolism
Czasopismo naukowe
Tytuł :
Clinical performances of an ELISA for SARS-CoV-2 antibody assay and correlation with neutralization activity.
Autorzy :
Padoan A; Department of Laboratory Medicine, University-Hospital of Padova, Italy; Department of Medicine-DIMED, University of Padova, Italy.
Zuin S; Department of Laboratory Medicine, University-Hospital of Padova, Italy; Department of Medicine-DIMED, University of Padova, Italy.
Cosma C; Department of Laboratory Medicine, University-Hospital of Padova, Italy; Department of Medicine-DIMED, University of Padova, Italy.
Basso D; Department of Laboratory Medicine, University-Hospital of Padova, Italy; Department of Medicine-DIMED, University of Padova, Italy.
Plebani M; Department of Laboratory Medicine, University-Hospital of Padova, Italy; Department of Medicine-DIMED, University of Padova, Italy. Electronic address: .
Bonfante F; Laboratory of Experimental Animal Models, Division of Comparative Biomedical Sciences, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.
Pokaż więcej
Źródło :
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2020 Nov; Vol. 510, pp. 654-655. Date of Electronic Publication: 2020 Aug 18.
Typ publikacji :
Letter
MeSH Terms :
Betacoronavirus*/isolation & purification
Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
Coronavirus Infections/*blood
Neutralization Tests/*standards
Pneumonia, Viral/*blood
COVID-19 ; Coronavirus Infections/diagnosis ; Enzyme-Linked Immunosorbent Assay/methods ; Enzyme-Linked Immunosorbent Assay/standards ; Humans ; Neutralization Tests/methods ; Pandemics ; Pneumonia, Viral/diagnosis ; SARS-CoV-2 ; Time Factors
Opinia redakcyjna
Tytuł :
Plaque Reduction Neutralization Test (PRNT) in the Congenital Zika Syndrome: Positivity and Associations with Laboratory, Clinical, and Imaging Characteristics.
Autorzy :
Ribeiro MRC; Department of Medicine III, Federal University of Maranhão, Praça Gonçalves Dias, 21, Centro, São Luís CEP 65020-240, MA, Brazil.
Khouri R; Laboratory of Vector-Borne Infectious Diseases, Gonçalo Moniz Institute, Fiocruz-Bahia, Rua Waldemar Falcão, 121, Candeal, Salvador CEP 40296-710, BA, Brazil.; Department of Pathology and Legal Medicine, Faculty of Medicine, Federal University of Bahia, Praça XV de Novembro, s/n-Largo do Terreiro de Jesus, Salvador CEP 40026-010, BA, Brazil.
Sousa PS; Reference Center on Neurodevelopment, Assistance and Rehabilitation of Children/NINAR- Health Secretariat of the State of Maranhão, Av. dos Holandeses, s/n, São Luís CEP 65077-357, MA, Brazil.
Branco MRFC; Department of Pathology, Federal University of Maranhão, Praça Madre Deus, 2, Madre Deus, São Luís CEP 65025-560, MA, Brazil.
Batista RFL; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Costa EPF; Department of Medicine I, Federal University of Maranhão, Praça Gonçalves Dias, 21, Centro, São Luís CEP 65020-240, MA, Brazil.
Alves MTSSB; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Amaral GA; Sarah Network of Neurorehabilitation Hospitals, Av. Luis Rocha, s/n, Monte Castelo, São Luís CP 65035-270, MA, Brazil.
Borges MCR; Diagnostic Imaging Department, Federal University of São Paulo, Rua Napoleão de Barros, 800, São Paulo CEP 04024-002, SP, Brazil.
Takahasi EHM; Sarah Network of Neurorehabilitation Hospitals, Av. Luis Rocha, s/n, Monte Castelo, São Luís CP 65035-270, MA, Brazil.
Gomes LN; Laboratory of Human Immunology, Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1730, Cidade Universitária, São Paulo CEP 05508-900, SP, Brazil.
Mendes AKT; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Cavalcante TB; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Costa LC; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Félix AC; Laboratory of Virology, Institute of Tropical Medicine, University of São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 470, São Paulo CEP 05403-000, SP, Brazil.
Souza NCS; Laboratory of Virology, Institute of Tropical Medicine, University of São Paulo, Av. Dr. Enéas Carvalho de Aguiar, 470, São Paulo CEP 05403-000, SP, Brazil.
Silva AAM; Department of Public Health, Federal University of Maranhão, Rua Barão de Itapary, 155, Centro, São Luís CEP 65020-070, MA, Brazil.
Pokaż więcej
Źródło :
Viruses [Viruses] 2020 Oct 31; Vol. 12 (11). Date of Electronic Publication: 2020 Oct 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neutralization Tests*
Viral Plaque Assay*
Zika Virus Infection/*congenital
Zika Virus Infection/*diagnosis
Brazil ; Child, Preschool ; Clinical Laboratory Techniques ; Cohort Studies ; Cross Reactions ; Female ; Humans ; Infant ; Pregnancy ; Serologic Tests ; Tomography
Czasopismo naukowe
Tytuł :
Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients.
Autorzy :
Deshpande GR; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Sapkal GN; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Tilekar BN; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Yadav PD; Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Gurav Y; Epidemiology Group, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Gaikwad S; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Kaushal H; Influenza Group, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Deshpande KS; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Kaduskar O; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Sarkale P; Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Baradkar S; Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Suryawanshi A; Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Lakra R; Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India.
Sugunan AP; ICMR-National Institute of Virology, Kerala Unit, Alappuzha, Kerala, India.
Balakrishnan A; ICMR-National Institute of Virology, Kerala Unit, Alappuzha, Kerala, India.
Abraham P; Diagnostic Virology Group, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Salve P; Medical Department, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Pokaż więcej
Źródło :
The Indian journal of medical research [Indian J Med Res] 2020 Jul & Aug; Vol. 152 (1 & 2), pp. 82-87.
Typ publikacji :
Journal Article
MeSH Terms :
Neutralization Tests*
Pandemics*
Antibodies, Neutralizing/*isolation & purification
Coronavirus Infections/*blood
Pneumonia, Viral/*blood
Adolescent ; Adult ; Animals ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/blood ; Betacoronavirus/immunology ; Betacoronavirus/pathogenicity ; COVID-19 ; Child ; Chlorocebus aethiops/immunology ; Coronavirus Infections/epidemiology ; Coronavirus Infections/immunology ; Coronavirus Infections/virology ; Female ; Humans ; Immunoglobulin G/blood ; Male ; Middle Aged ; Pneumonia, Viral/epidemiology ; Pneumonia, Viral/immunology ; Pneumonia, Viral/virology ; SARS-CoV-2 ; Vero Cells/immunology ; Young Adult
Czasopismo naukowe
Tytuł :
An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies.
Autorzy :
Ahmadi S; Department of Biotechnology and Biosafety, Graduate School of Natural and Applied Sciences, Eskisehir Osmangazi University, Eskisehir, Turkey.; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Pucca MB; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.; Medical School, Federal University of Roraima, Boa Vista, Roraima, Brazil.
Jürgensen JA; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Janke R; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Ledsgaard L; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Schoof EM; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Sørensen CV; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark.
Çalışkan F; Department of Biotechnology and Biosafety, Graduate School of Natural and Applied Sciences, Eskisehir Osmangazi University, Eskisehir, Turkey.; Department of Biology, Faculty of Science and Letters, Eskisehir Osmangazi University, Eskisehir, Turkey.
Laustsen AH; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Jul 01; Vol. 10 (1), pp. 10765. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Neutralization Tests*
Antibodies, Monoclonal/*chemistry
Antibodies, Neutralizing/*chemistry
Antivenins/*chemistry
Animals ; Antigens/chemistry ; Biotechnology ; Cross Reactions/immunology ; Drug Design ; Enzyme-Linked Immunosorbent Assay ; Humans ; Immunoglobulin Fab Fragments/immunology ; In Vitro Techniques ; Inhibitory Concentration 50 ; Keratinocytes/immunology ; Mass Spectrometry ; Peptide Library ; Proteomics ; Recombinant Proteins/chemistry ; Snakes ; Venoms
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies